RecruitingNCT06702891

Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer


Sponsor

Qilu Hospital of Shandong University

Enrollment

20 participants

Start Date

Dec 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational study with a case control design. This study included patients with gastric cancer confirmed by pathological diagnosis of gastric tissue, and matched the control population according to age, gender, etc. In this study, researchers collected clinical information and multiple biological samples such as serum and tissue tissue from the study subjects. The researchers combined exosome sequencing, proteomics and single-cell RNA sequencing to explore the heterogeneity of cardia cancer, identify specific biomarkers and potential therapeutic targets for cardia cancer, and provide a basis for the development of new diagnostic tools and therapeutic strategies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This research study is collecting tissue and fluid samples from people with stomach cancer (including early and advanced stages) to study tiny particles called exosomes that cancer cells release, which may reveal information about how the cancer grows and spreads. **You may be eligible if...** - You are 18 or older - You have had an endoscopy and been confirmed to have stomach cancer (including high-grade pre-cancer, early, or advanced gastric cancer) - You are willing to provide informed consent **You may NOT be eligible if...** - You have had gastrointestinal surgery in the past year - You have undergone pre-surgery chemotherapy with cancer in a previously operated stomach - You have taken proton pump inhibitors, antibiotics, or probiotics daily in the past month - You have inflammatory bowel disease, irritable bowel syndrome, or another digestive condition that could affect the study results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDetection of biological samples based on exosome sequencing, proteomics and single-cell RNA sequencing

The researchers combined exosome sequencing, proteomics and single-cell RNA sequencing to explore the heterogeneity of cardia cancer, identify specific biomarkers and potential therapeutic targets for cardia cancer.


Locations(1)

Qilu Hospital of Shandong University

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06702891